ArticleFrontiers in oncology2022

Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells.

Hongqing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.